These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 15871855)
21. Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study. Jacobson TA; Gutkin SW; Harper CR Curr Med Res Opin; 2006 Jun; 22(6):1065-73. PubMed ID: 16846539 [TBL] [Abstract][Full Text] [Related]
22. Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors. Milne R; Gamble G; Whitlock G; Jackson R N Z Med J; 2003 Nov; 116(1185):U663. PubMed ID: 14615805 [TBL] [Abstract][Full Text] [Related]
23. Consequences of using different methods to assess cardiovascular risk in primary care. Fornasini M; Brotons C; Sellarès J; Martinez M; Galán ML; Sáenz I; da Pena JM Fam Pract; 2006 Feb; 23(1):28-33. PubMed ID: 16243952 [TBL] [Abstract][Full Text] [Related]
24. Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: findings from 12 Italian population samples. Giampaoli S; Palmieri L; Panico S; Vanuzzo D; Ferrario M; Chiodini P; Pilotto L; Donfrancesco C; Cesana G; Sega R; Stamler J Am J Epidemiol; 2006 May; 163(10):893-902. PubMed ID: 16554350 [TBL] [Abstract][Full Text] [Related]
25. [Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment]. Buitrago F; Cañón-Barroso L; Díaz-Herrera N; Cruces-Muro E; Escobar-Fernández M; Serrano-Arias JM Rev Esp Cardiol; 2007 Feb; 60(2):139-47. PubMed ID: 17338879 [TBL] [Abstract][Full Text] [Related]
26. [The best of epidemiology and cardiovascular prevention in 2006]. Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular disease knowledge and risk perception among underserved individuals at increased risk of cardiovascular disease. Homko CJ; Santamore WP; Zamora L; Shirk G; Gaughan J; Cross R; Kashem A; Petersen S; Bove AA J Cardiovasc Nurs; 2008; 23(4):332-7. PubMed ID: 18596496 [TBL] [Abstract][Full Text] [Related]
28. [Overview of the scoring system for cardiovascular risk estimation: role and significance of lipids]. Savić T; Tasić I; Janković D; Bojanić V; Janković I; Miladinović-Tasić N Med Pregl; 2009; 62 Suppl 3():24-32. PubMed ID: 19702112 [TBL] [Abstract][Full Text] [Related]
30. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers. Wells S; Broad J; Jackson R N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394 [TBL] [Abstract][Full Text] [Related]
31. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?]. Kung M; Störk S; Angermann CE Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682 [TBL] [Abstract][Full Text] [Related]
33. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension. Ruilope LM; Segura J Clin Ther; 2005 Oct; 27(10):1658-68. PubMed ID: 16330303 [TBL] [Abstract][Full Text] [Related]
34. Preventing cardiovascular disease in women. Hayes SN Am Fam Physician; 2006 Oct; 74(8):1331-40. PubMed ID: 17087427 [TBL] [Abstract][Full Text] [Related]
35. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations. Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076 [TBL] [Abstract][Full Text] [Related]
36. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men. Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700 [TBL] [Abstract][Full Text] [Related]
37. [Calculation of the absolute cardiovascular risk in practice]. Mayaudon H; Dupuy O; Bordier L; Sarret D; Bauduceau B Diabetes Metab; 2001 Feb; 27(1):82-6. PubMed ID: 11240453 [TBL] [Abstract][Full Text] [Related]
38. [Guidelines for the elaboration of programs for the primary prevention of cardiovascular diseases. The Working Group for Primary Cardiovascular Prevention]. Banegas Banegas JR; Díez García MA; Sánchez RG; Gómez Esmorís L; Jiménez García-Pascual R; Juane Sánchez R; Juncadella García E; Martín Zurro A; Muñiz García J; Pérez Andrés C Rev Sanid Hig Publica (Madr); 1993; 67(1):5-22. PubMed ID: 7725051 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular disease in Chinese women: an emerging high-risk population and implications for nursing practice. Cao Y; DiGiacomo M; Du HY; Ollerton E; Davidson P J Cardiovasc Nurs; 2008; 23(5):386-94; quiz 395-6. PubMed ID: 18728510 [TBL] [Abstract][Full Text] [Related]
40. Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk. Rafter N; Connor J; Hall J; Jackson R; Martin I; Parag V; Vander Hoorn S; Rodgers A N Z Med J; 2005 Oct; 118(1223):U1676. PubMed ID: 16224500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]